NY-ESO-1 TCR (c259) CD8+ NFAT-Luciferase Reporter Jurkat Cell Line 返回列表页

举报评价

参考价

面议

具体成交价以合同协议为准

产品型号78771

品牌BPS Bioscience

厂商性质生产商

所在地

在线询价加入对比查看联系电话

更新时间：2023-12-15 12:09:22浏览次数：65次

联系我时，请告知来自化工仪器网

同类优质产品更多>

Anti-BCMA CAR /

参考价￥面议
Anti-CD20 CAR-T

参考价￥面议
Anti-Mesothelin

参考价￥面议
Anti-CD19 CAR /

参考价￥面议
B2M Knockout Ju

参考价￥面议

产品分类品牌分类

CAR T-Cell Therapy Cell Lines

全部产品列表

产品简介

●Purchase●DescriptionThiscelllinewasgeneratedfromtheTCellReceptor(TCR)KnockoutNFATLuciferaseReporterJurkatCellLine(BPSBioscience#78556)byoverexpressionofhumanCD8(NM_001768

详情介绍

●

Purchase

●

Description

This cell line was generated from the T Cell Receptor (TCR) Knockout NFAT Luciferase Reporter Jurkat Cell Line (BPS Bioscience #78556) by overexpression of human CD8 (NM_001768.6) and NY-ESO-1 TCR (c259) using lentiviral transduction (CD8a Lentivirus #78648 and NY-ESO-1 -Specific TCR Lentivirus Clone c259 #78676). The human TCR clone c259 that specifically recognizes antigen NY-ESO-1 (New York esophageal squamous cell carcinoma 1).

Figure 1: Illustration of the functional co-culture assay used to validate the NY-ESO-1 TCR (c259) CD8⁺ NFAT-Luciferase Reporter Jurkat cell line.

Purchase of this cell line is for research purposes only; commercial use requires a separate license. View the full terms and conditions.

●

Product Data Gallery